NCT01653444View on ClinicalTrials.gov

Evaluate the Safety and Exploratory Efficacy of GC1119

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

May 31, 2014

Study Completion Date

October 31, 2015

Conditions
Fabry Disease
Interventions
DRUG

GC1119

biweekly, IV infusion

Trial Locations (3)

Unknown

Asan Medical Center, Songpa-gu

Soon Cung Hyang University Hospital, Yongsan-gu

Ajou University School of Medicine, Yeongtong-gu

Sponsors
All Listed Sponsors
lead

Green Cross Corporation

INDUSTRY